Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma

In this online educational program, expert faculty explore optimal care for patients with Hodgkin lymphoma including risk-adapted and response-adapted therapeutic strategies, management of both early and late disease relapse, treatment of progressive disease post transplantation, considerations for elderly patients, and emerging treatment approaches.
Ranjana Advani, MD
Program Director
Robert W. Chen, MD
Andrew M. Evens, DO, MSc, FACP
Pier Luigi Zinzani, MD, PhD

On-Demand Webcast

In this on-demand Webcast of a CCO symposium at ASH 2017, Ranjana Advani, MD, leads an expert panel with Robert W. Chen, MD; Andrew Evens, DO, MSc, FACP; and Pier Luigi Zinzani, MD, PhD, as they review and discuss the latest clinical strategies for managing patients with Hodgkin lymphoma.

Ranjana Advani, MD
Program Director
Robert W. Chen, MD Andrew M. Evens, DO, MSc, FACP Pier Luigi Zinzani, MD, PhD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: January 24, 2018 Expiration: January 23, 2019

Downloadable Slidesets

In this downloadable slideset, Ranjana Advani, MD, provides an overview of Hodgkin lymphoma epidemiology, current prognostic risk factors used in clinic, and emerging biomarkers for risk assessment in patients with this disease.

Released: December 12, 2017

In this downloadable slideset, Ranjana Advani, MD, reviews available evidence regarding the initial treatment of patients diagnosed with classical Hodgkin lymphoma.

Released: December 13, 2017

In this downloadable slideset, Robert W. Chen, MD, presents current evidence supporting the management of HL in transplantation-eligible patients.

Released: December 14, 2017

In this downloadable slideset, Pier Luigi Zinzani, MD, PhD, reviews current and emerging data relevant to the treatment of patients with primary refractory classical Hodgkin lymphoma.

Released: December 12, 2017

In this downloadable slideset, Andrew M. Evens, DO, MSc, FACP, discusses current evidence for the management of HL in patients aged 60 years and older.

Released: December 12, 2017

In this downloadable slideset, Pier Luigi Zinzani, MD, PhD, reviews current and emerging data relevant to the treatment of patients with classical Hodgkin lymphoma and progression following stem cell transplantation.

Released: December 12, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by educational grants from
Merck & Co., Inc.
Takeda Oncology
Seattle Genetics

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?